MarkAlanYarboroughMD

PubMed

• 1 citations
  Twentieth-century science education and 21st-century genetic engineering technologies: A toxic mix.
  Mark A Yarborough> ;Accountability in Research. 2019 Apr 12
• 4 citations
  Ethical issues related to clinical research and rare diseases: 15th Gordon L. Snider Critical Issues Workshop, April 1, 2016, Bethesda, Maryland.
  Marilyn E. Coors, Larry Bauer, Kelly Edwards, Karen Erickson, Aaron J. Goldenberg, John Goodale, Kenneth S. Goodman, Christine Grady, David M. Mannino, Adam Wanner, To...> ;Translational Science of Rare Diseases. 2017 Dec 18
• 27 citations
  “Editing” Genes: A Case Study About How Language Matters in Bioethics
  Meaghan O'Keefe, Sarah Tinker Perrault, Jodi Halpern, Lisa C. Ikemoto, Mark A Yarborough> ;The American Journal of Bioethics. 2015 Dec 2
• 4 citations
  Inconsistent Approaches to Research Involving Cognitively Impaired Adults: Why the Broad View of Substituted Judgment Is Our Best Guide.
  Mark A Yarborough> ;The American Journal of Bioethics. 2015 Oct 19
• When There Are Only Two Who Can Tango: Ethical Concerns at the Juncture of Highly Novel Interventions and Precisely Targeted Research Populations
  Mark A Yarborough> ;The American Journal of Bioethics. 2015 Apr 9
• Relationships hold the key to trustworthy and productive translational science: recommendations for expanding community engagement in biomedical research.
  Yarborough, M.,Edwards, K.,Espinoza, P.,Geller, G.,Sarwal, A.,Sharp, R.,Spicer, P.> ;Clin Transl Sci. 2013 Aug
• 20 citations
  Newborn screening and cascade testing for FMR1 mutations
  Page L. Sorensen, Louise W. Gane, Mark A Yarborough, Randi J Hagerman, Flora Tassone> ;American Journal of Medical Genetics. Part A. 2013 Jan 1
• 7 citations
  Teaching Research Ethics Better: Focus on Excellent Science, Not Bad Scientists
  Mark A Yarborough, Lawrence Hunter> ;Clinical and Translational Science. 2013 Jun 1
• 5 citations
  Increasing enrollment in drug trials: the need for greater transparency about the social value of research in recruitment efforts.
  Mark A Yarborough> ;Mayo Clinic Proceedings. 2013 May 1
• 23 citations
  Public trust and research a decade later: what have we learned since Jesse Gelsinger's death?
  Mark A Yarborough, Richard R. Sharp> ;Molecular Genetics and Metabolism. 2009 May 1
• 26 citations
  Transforming the culture of biomedical research from compliance to trustworthiness: insights from nonmedical sectors.
  Mark A Yarborough, Kelly Fryer-Edwards, Gail Geller, Richard R. Sharp> ;Academic Medicine. 2009 Apr 1
• 3 citations
  Responsible patient advocacy: perspectives from the Alpha-1 Foundation.
  Richard R. Sharp, Mark A Yarborough, John W. Walsh> ;American Journal of Medical Genetics. Part A. 2008 Nov 15
• 7 citations
  Bioethics consultation and patient advocacy organizations: expanding the dialogue about professional conflicts of interest.
  Mark A Yarborough, Richard R. Sharp> ;Cambridge Quarterly of Healthcare Ethics. 2007 Jan 1
• 6 citations
  Informed trust and the financing of biomedical research.
  Richard R. Sharp, Mark A Yarborough> ;The Journal of Law, Medicine & Ethics. 2006 Jun 1
• 4 citations
  Additional thoughts on rethinking research ethics.
  Richard R. Sharp, Mark A Yarborough> ;The American Journal of Bioethics. 2005 Jan 1
• 25 citations
  Restoring and preserving trust in biomedical research.
  Mark A Yarborough, Richard R. Sharp> ;Academic Medicine. 2002 Jan 1
• 25 citations
  Interprofessional education in ethics at an academic health sciences center.
  Mark A Yarborough, Therese Tess Jones, Thomas A. Cyr, Sally Phillips, Denise Stelzner> ;Academic Medicine. 2000 Aug 1
• 26 citations
  Incidence and clinical significance of subclinical scrotal varicoceles.
  Mark A. Yarborough, John R. Burns, Frederick S. Keller> ;The Journal of Urology. 1989 Jun 1
• 6 citations
  The Physician and Resource Allocation
  Mark A Yarborough, Andrew M. Kramer> ;Clinics in Geriatric Medicine. 1986 Aug 1
• Join now to see all